FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+7.26%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$21.4B
AUM Growth
+$442M
(+2.1%)
Cap. Flow
-$751M
Cap. Flow
% of AUM
-3.51%
Top 10 Holdings %
Top 10 Hldgs %
37.36%
Holding
583
New
44
Increased
179
Reduced
225
Closed
76
Top Buys
| 1 |
Sherwin-Williams
SHW
|
$143M |
| 2 |
Stanley Black & Decker
SWK
|
$118M |
| 3 |
Equinix
EQIX
|
$89.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
$85.7M |
| 5 |
Norwegian Cruise Line
NCLH
|
$85M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$140M |
| 2 |
Comcast
CMCSA
|
$130M |
| 3 |
Walt Disney
DIS
|
$125M |
| 4 |
Honeywell
HON
|
$117M |
| 5 |
Philip Morris
PM
|
$102M |
Sector Composition
| 1 | Technology | 27.6% |
| 2 | Communication Services | 15.09% |
| 3 | Consumer Discretionary | 14.71% |
| 4 | Healthcare | 14.53% |
| 5 | Financials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
326
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $978K | ﹤0.01% |
29,675
-278
| -0.9% | -$9.16K |
|
327
Ciena
CIEN
$16.5B
| $961K | ﹤0.01% |
43,732
-5,000
| -10% | -$110K |
|
328
SAP
SAP
$313B
| $956K | ﹤0.01% |
8,716
| – | – |
|
329
Ulta Beauty
ULTA
$23.1B
| $929K | ﹤0.01% |
4,110
-3,460
| -46% | -$782K |
|
|
WBA
330
DELISTED
Walgreens Boots Alliance
WBA
| $905K | ﹤0.01% |
11,720
-161
| -1% | -$12.4K |
|
331
West Pharmaceutical
WST
$18B
| $866K | ﹤0.01% |
9,000
-4,000
| -31% | -$385K |
|
332
Cheniere Energy
CQP
$26.1B
| $851K | ﹤0.01% |
29,522
-744
| -2% | -$21.4K |
|
333
AstraZeneca
AZN
$253B
| $813K | ﹤0.01% |
24,000
-38,000
| -61% | -$1.29M |
|
334
Allegion
ALLE
$14.8B
| $761K | ﹤0.01% |
8,798
-134
| -2% | -$11.6K |
|
335
Qiagen
QGEN
$10.3B
| $756K | ﹤0.01% |
22,633
+20,275
| +860% | +$677K |
|
336
ProPetro Holding
PUMP
$496M
| $743K | ﹤0.01% |
51,803
-198,724
| -79% | -$2.85M |
|
337
Credicorp
BAP
$20.7B
| $742K | ﹤0.01% |
3,617
-483
| -12% | -$99.1K |
|
338
Alkermes
ALKS
$4.94B
| $737K | ﹤0.01% |
+14,500
| New | +$737K |
|
|
FPRX
339
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $736K | ﹤0.01% |
18,000
+3,000
| +20% | +$123K |
|
340
Tetra Tech
TTEK
$9.48B
| $735K | ﹤0.01% |
78,965
| – | – |
|
|
AVXS
341
DELISTED
AveXis, Inc. Common Stock
AVXS
| $725K | ﹤0.01% |
+7,500
| New | +$725K |
|
|
RDUS
342
DELISTED
Radius Health, Inc.
RDUS
| $694K | ﹤0.01% |
18,000
+10,000
| +125% | +$386K |
|
343
Merck
MRK
$212B
| $675K | ﹤0.01% |
11,050
-15,720
| -59% | -$960K |
|
344
Lockheed Martin
LMT
$108B
| $670K | ﹤0.01% |
2,159
| – | – |
|
345
Citigroup
C
$176B
| $638K | ﹤0.01% |
8,773
+8,410
| +2,317% | +$612K |
|
346
GeoPark
GPRK
$326M
| $631K | ﹤0.01% |
72,371
+11,423
| +19% | +$99.6K |
|
|
SAGE
347
DELISTED
Sage Therapeutics
SAGE
| $624K | ﹤0.01% |
10,009
+1,000
| +11% | +$62.3K |
|
348
eBay
EBAY
$42.3B
| $577K | ﹤0.01% |
15,002
-490,290
| -97% | -$18.9M |
|
349
3M
MMM
$82.7B
| $570K | ﹤0.01% |
3,246
-1,757
| -35% | -$309K |
|
|
BPMC
350
DELISTED
Blueprint Medicines
BPMC
| $557K | ﹤0.01% |
8,000
+4,000
| +100% | +$279K |
|